Figure 1.
TTP of RCC xenografts treated with vehicle, sunitinib, everolimus, and sequences. Mice groups according to the treatment protocols (A) Kaplan–Meier evaluations for mice treated with 60 mg kg−1 per day sunitinib, 10 mg kg−1 per day everolimus, sequential combination of 60 mg kg−1per day sunitinib, and 10 mg kg−1 per day everolimus as a single group (B) composed with treatment of alternate drugs administration every week (1W), every 2 weeks (2W), and every 3 weeks (3W) (C).